112 related articles for article (PubMed ID: 21748650)
1. Inhibition of human papillomavirus expression using DNAzymes.
Benítez-Hess ML; Reyes-Gutiérrez P; Alvarez-Salas LM
Methods Mol Biol; 2011; 764():317-35. PubMed ID: 21748650
[TBL] [Abstract][Full Text] [Related]
2. Cleavage of HPV-16 E6/E7 mRNA mediated by modified 10-23 deoxyribozymes.
Reyes-Gutiérrez P; Alvarez-Salas LM
Oligonucleotides; 2009 Sep; 19(3):233-42. PubMed ID: 19732021
[TBL] [Abstract][Full Text] [Related]
3. Targeting insulin-like growth factor I with 10-23 DNAzymes: 2'-O-methyl modifications in the catalytic core enhance mRNA cleavage.
Fokina AA; Meschaninova MI; Durfort T; Venyaminova AG; François JC
Biochemistry; 2012 Mar; 51(11):2181-91. PubMed ID: 22352843
[TBL] [Abstract][Full Text] [Related]
4. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
[TBL] [Abstract][Full Text] [Related]
5. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
6. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis.
Lu ZX; Ye M; Yan GR; Li Q; Tang M; Lee LM; Sun LQ; Cao Y
Cancer Gene Ther; 2005 Jul; 12(7):647-54. PubMed ID: 15803142
[TBL] [Abstract][Full Text] [Related]
7. [Target of developing the new anti-influenza virus reagents].
Toyoda T
Nihon Rinsho; 2003 Nov; 61(11):1980-6. PubMed ID: 14619442
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatitis B virus X gene expression by 10-23 DNAzymes.
Hou W; Ni Q; Wo J; Li M; Liu K; Chen L; Hu Z; Liu R; Hu M
Antiviral Res; 2006 Dec; 72(3):190-6. PubMed ID: 16930733
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined antisense oligodeoxynucleotides directed against the human papillomavirus type 16 on cervical carcinoma cells.
Márquez-Gutiérrez MA; Benítez-Hess ML; DiPaolo JA; Alvarez-Salas LM
Arch Med Res; 2007 Oct; 38(7):730-8. PubMed ID: 17845891
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic oligonucleotides.
Goodchild J
Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
12. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
[TBL] [Abstract][Full Text] [Related]
13. [Cleavage of telomerase RNA component by two DNAzymes and their effects on expression of two apoptosis-related genes in human mammary cancer cells].
Zhao JM; Li MY; Yang Z; Li Z; Zhang Y
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):638-42. PubMed ID: 15958297
[TBL] [Abstract][Full Text] [Related]
14. Gaining target access for deoxyribozymes.
Schubert S; Fürste JP; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
J Mol Biol; 2004 May; 339(2):355-63. PubMed ID: 15136038
[TBL] [Abstract][Full Text] [Related]
15. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Kraemer K; Fuessel S; Schmidt U; Kotzsch M; Schwenzer B; Wirth MP; Meye A
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3794-800. PubMed ID: 14506173
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of respiratory syncytial virus in cultured cells by nucleocapsid gene targeted deoxyribozyme (DNAzyme).
Xie YY; Zhao XD; Jiang LP; Liu HL; Wang LJ; Fang P; Shen KL; Xie ZD; Wu YP; Yang XQ
Antiviral Res; 2006 Aug; 71(1):31-41. PubMed ID: 16687180
[TBL] [Abstract][Full Text] [Related]
17. DNAzymes as potential therapeutic molecules.
Isaka Y
Curr Opin Mol Ther; 2007 Apr; 9(2):132-6. PubMed ID: 17458166
[TBL] [Abstract][Full Text] [Related]
18. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines.
Steele C; Cowsert LM; Shillitoe EJ
Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572
[TBL] [Abstract][Full Text] [Related]
19. A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells.
Takahashi H; Hamazaki H; Habu Y; Hayashi M; Abe T; Miyano-Kurosaki N; Takaku H
FEBS Lett; 2004 Feb; 560(1-3):69-74. PubMed ID: 14988000
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of papilloma progression by antisense oligonucleotides targeted to HPV11 E6/E7 RNA.
Clawson GA; Miranda GQ; Sivarajah A; Xin P; Pan W; Thiboutot D; Christensen ND
Gene Ther; 2004 Sep; 11(17):1331-41. PubMed ID: 15229628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
